Skip to main content

Table 1 baseline characteristics

From: Diaphragmatic parameters by ultrasonography for predicting weaning outcomes

Demographic data

Value

Age (mean ± SD, years)

66.48 ± 16.7

Genders Male (n/%)

38/61

Body mass index (mean ± SD, kg/m2)

22.5 ± 6.3

Medical patients (n/%)

42/68

Surgical patients (n/%)

20/32

APACHE II score (mean ± SD)

18.5 ± 7.2

Comorbidity (n/%)

 Hypertension

35/57

 Diabetes

21/34

 Chronic kidney disease

18/29

 Ischemic heart disease

14/23

 COPD

6/10

 Hypothyroid

5/8

 Adrenal insufficiency

3/5

 Asthma

2/3

Reason for intubation (n/%)

 Neurological disease

10/16

 Septic shock

10/16

 Pneumonia

8/13

 Heart disease

8/13

 COPD exacerbation

4/7

 Post-operative conditions

21/34

Laboratory findings (mean ± SD)

 Sodium (mmol/L)

135.9 ± 5.2

 Potassium (mmol/L)

3.9 ± 0.59

 Bicarbonate (mmol/L)

23.6 ± 4.5

 Calcium (mmol/L)

7.9 ± 0.65

 Magnesium (mmol/L)

1.97 ± 0.37

 Phosphate (mmol/L)

4.6 ± 5.4

 Albumin (g/dl)

24.8 ± 5.6

 BUN (mg/dl)

29.3 ± 23.9

 Creatinine (mg/dl)

1.9 ± 2.3

 Hematocrit (%)

31.8 ± 5.5

Vital capacity (mean ± SD, L)

0.97 ± 0.4

Tidal volume (mean ± SD, L)

0.41 ± 0.2

PIMAX (mean ± SD, mmHg)

40.7 ± 16.4

RSBI (mean ± SD, breath•min− 1/L)

60.2 ± 33.1

Duration of mechanical ventilation(days) a

2.8(1.1–5.7)

Length of stay (days)

 

 Intensive care staya

4.8 (2.9–9.6)

 Hospital staya

13.3 (7.8–25.9)

  1. APACHE II Acute Physiology and Chronic Health Evaluation II, COPD chronic obstructive airway disease, BUN blood urea nitrogen, PIMAX Maximum peak inspiratory pressure, RSBI Rapid shallow breathing index
  2. apresent as median (inter quartile range)